Pricing Log in Create free account

Soligenix Inc. (SNGX) vs Alaunos Therapeutics, Inc. (TCRT)

Soligenix Inc. and Alaunos Therapeutics, Inc. are both Biotechnology companies. Soligenix Inc. and Alaunos Therapeutics, Inc. are of similar size ($7.6M and $7.3M). Alaunos Therapeutics, Inc. grew revenue faster over the last twelve months: −17.7% against −50.4%. Across the 14 metrics below, Soligenix Inc. leads on 7 and Alaunos Therapeutics, Inc. on 7.

Valuation

Metric SNGX TCRT Biotechnology median
P/E n/m n/m 10.26
P/S 10.97 314.42 9.18
P/B 0.82 6.75 2.05
Price to free cash flow n/m n/m 24.81
EV/EBITDA 0.18 n/m 0.65
EV/Sales (4.05) 1,409.85 8.98
Earnings yield (372.59%) (106.78%) (34.89%)
Free cash flow yield (179.73%) (30.01%) (24.52%)

Profitability

Metric SNGX TCRT Biotechnology median
Gross margin 0.00% 100.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (241.65%) (185.95%) (50.12%)
Return on assets (125.95%) (128.30%) (45.60%)
Return on invested capital 0.00% (480.35%) 0.00%

Growth

Metric SNGX TCRT Biotechnology median
Revenue growth (TTM) (50.37%) (17.65%) 6.26%
EPS growth (last fiscal year) 57.03% 24.66% 29.88%
Revenue growth, 5-year CAGR (51.88%) (49.08%) 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric SNGX TCRT Biotechnology median
Debt to equity 0.00 0.00 0.00
Current ratio 2.77 0.77 4.89
Net debt to EBITDA 0.67 0.33 1.01

Dividend

Metric SNGX TCRT Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric SNGX TCRT Biotechnology median
Market cap 7.26m 7.60m 172.11m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack